Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Histone point mutations are epigentic drivers of pediatric hemispheric high grade glioma

EF 2016-17

Résumé
Brain tumors are the most common, and leading cause of cancer related death in pediatric patients. Pediatric high grade astrocytomas, a common form of brain tumor, have a near 100% fatality. Several factors contribute to this poor survival including the lack of targeted therapies and the lack of pre-clinical models. Recent characterization of pediatric high grade astrocytoma by our lab and other have discovered a novel specific histone mutation that represents approximately 20% of pediatric high grade astrocytoma.Histones are highly expressed in all cells and are closely associated with DNA, the blueprint for all organisms. Through their interactions, histones can modulate the reading of the DNA blueprints. In addition, histones play a crucial role in recruiting machineries that repair damaged DNA.With a high occurrence of histones mutations in pediatric high grade glioma, understanding the consequences of this mutation is needed to develop effective therapeutics. In my project I will be create a cell line carrying the histone mutation, using a novel precise genome editing tool called CRISPR. These cells will be studied to understand how histone mutations mediate tumor formation. Furthermore, I will investigate the effects of histone mutation on DNA repair pathway. Identification of deficiencies in DNA reparability can uncover vulnerabilities that can be targeted in developing tumor specific therapeutics. Lastly, I will be creating a mouse line carrying the histone mutations to mimic the clinical observation of pediatric high grade astrocytoma and study the development of the tumor.Ultimately, my research will be the first to develop and study the genetic model of this mutation in cancer.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
367187
Name
Kim Byungjin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Histone point mutations are epigentic drivers of pediatric hemispheric high grade glioma
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Brain; Cancer; Epigenetics; Genetics; Glioma; Histone
Abstract
Brain tumors are the most common, and leading cause of cancer related death in pediatric patients. Pediatric high grade astrocytomas, a common form of brain tumor, have a near 100% fatality. Several factors contribute to this poor survival including the lack of targeted therapies and the lack of pre-clinical models. Recent characterization of pediatric high grade astrocytoma by our lab and other have discovered a novel specific histone mutation that represents approximately 20% of pediatric high grade astrocytoma.Histones are highly expressed in all cells and are closely associated with DNA, the blueprint for all organisms. Through their interactions, histones can modulate the reading of the DNA blueprints. In addition, histones play a crucial role in recruiting machineries that repair damaged DNA.With a high occurrence of histones mutations in pediatric high grade glioma, understanding the consequences of this mutation is needed to develop effective therapeutics. In my project I will be create a cell line carrying the histone mutation, using a novel precise genome editing tool called CRISPR. These cells will be studied to understand how histone mutations mediate tumor formation. Furthermore, I will investigate the effects of histone mutation on DNA repair pathway. Identification of deficiencies in DNA reparability can uncover vulnerabilities that can be targeted in developing tumor specific therapeutics. Lastly, I will be creating a mouse line carrying the histone mutations to mimic the clinical observation of pediatric high grade astrocytoma and study the development of the tumor.Ultimately, my research will be the first to develop and study the genetic model of this mutation in cancer.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Kim, Byungjin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~